Use of an affinity immunosorbent for the isolation of lactoferrin from breast milk serum

1986 ◽  
Vol 22 (6) ◽  
pp. 697-698
Author(s):  
A. A. Buglanov
Keyword(s):  
Data in Brief ◽  
2016 ◽  
Vol 7 ◽  
pp. 362-365 ◽  
Author(s):  
Lina Zhang ◽  
Marita de Waard ◽  
Hester Verheijen ◽  
Sjef Boeren ◽  
Jos A. Hageman ◽  
...  

2016 ◽  
Vol 147 ◽  
pp. 40-47 ◽  
Author(s):  
Lina Zhang ◽  
Marita de Waard ◽  
Hester Verheijen ◽  
Sjef Boeren ◽  
Jos A. Hageman ◽  
...  

2021 ◽  
Vol 171 (4) ◽  
pp. 525-528
Author(s):  
T. I. Kolyganova ◽  
◽  
V. G. Arzumanyan ◽  
E. A. Bogdanova ◽  
V. V. Zverev ◽  
...  

2021 ◽  
Author(s):  
Miriam Sanso ◽  
Cristina Saura ◽  
Carolina Ortiz ◽  
Enrique Arenas Lahuerta ◽  
Judit Matito ◽  
...  

Abstract Pregnancy associated breast cancer (PABC) is an overall poor prognosis group compared to non-PABC breast cancer (BC), mainly due to late diagnosis. Effective screening approaches for early detection may improve its outcome. For the first time, we demonstrate the presence of cell-free tumor DNA (ctDNA) in the breast milk serum (sBM) of PABC in patients with early-stage disease and its ability to recapitulate somatic mutations present in the primary tumor. Moreover, our results demonstrate that sBM robustly surpasses plasma for tumor genetic profiling due to a prevalent shedding of ctDNA into the sBM in localized disease, as well as increased total cell-free DNA (cfDNA) abundance and integrity. Thus, we propose sBM as a potential new non-invasive liquid biopsy for a prompt detection of PABC.


1996 ◽  
Vol 30 (2) ◽  
pp. 148-150 ◽  
Author(s):  
Antonio J Carcas ◽  
Francisco Abad-Santos ◽  
Jesús M de Rosendo ◽  
Jesús Frias

OBJECTIVE: To report nimodipine concentrations in breast milk and cerebrospinal fluid (CSF) of a lactating woman who was given the drug to prevent a vascular spasm secondary to angiographic examination. METHODS: A 36-year-old woman received a total dose of nimodipine 46 mg iv over 24 hours. She extracted milk when she noted mammary tightness, and blood samples were taken simultaneously by venipuncture in the arm contralateral to that of the nimodipine infusion. A CSF sample also was taken in a diagnostic lumbar puncture. RESULTS: Nimodipine concentration in milk was much lower than that in serum, with a milk/serum ratio of 0.06–0.15. The CSF/serum ratio was 0.01. We estimate that the infant would have received between 0.008% and 0.092% of the weight-adjusted dose that was administered to the mother if the baby had been nursed. CONCLUSIONS: Nimodipine is transferred to human milk in a lower proportion than are other calcium-channel blockers. These results suggest that treating the mother with nimodipine would entail no risk to the nursing infant.


2021 ◽  
Vol 171 (4) ◽  
pp. 504-507
Author(s):  
T. I. Kolyganova ◽  
V. G. Arzumanyan ◽  
E. A. Bogdanova ◽  
V. V. Zverev

2001 ◽  
Vol 120 (5) ◽  
pp. A209-A209
Author(s):  
G RIEZZO ◽  
R CASTELLANA ◽  
T DEBELLIS ◽  
F LAFORGIA ◽  
F INDRIO ◽  
...  

Ob Gyn News ◽  
2007 ◽  
Vol 42 (22) ◽  
pp. 13
Author(s):  
TIMOTHY F. KIRN
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document